Risk factors for relapse in drug-dependent patients after hospital detoxification;Factores de riesgo de recaída en pacientes drogodependientes tras desintoxicación hospitalaria

Adicciones

Volumn 24, Issue 2, 2012, Pages 115-122

  Grau López, Lara ^a   Roncero, Carlos ^a,b   Daigre, Constanza ^a   Gonzalvo, Begoña ^a   Bachiller, Diana ^a   Rodriguez Cintas, Laia ^a   Egido, Ángel ^a   Casas, Miquel ^a,b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Addiction; Follow up; In patient unit; Relapses; Risk factors

Indexed keywords

ADDICTION; ADULT; ARTICLE; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; MALE; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDY; RECURRENT DISEASE; RISK FACTOR;

ADULT; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; MALE; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 84861891529     PISSN: 02144840     EISSN: None     Source Type: Journal    
DOI: 10.20882/adicciones.103     Document Type: Article

References (44)

1. Backmund, M., Meyer, K., Eichenlaub, D. y Schutz, C. G. (2001). Predictors for completing an inpatient detoxification program among intravenous heroin users, methadone substituted and codeine substituted patients. Drug and Alcohol Dependence, 64,173-180. doi: 10.1016/S0376-8716(01)00122-3
2. Cervera, G., Valderrama, J. C., Bolinches, F. y Martínez, J. (1999). Pauta de desintoxicación frente a estabilización y mantenimiento con metadona en adictos a opiáceos con trastorno de personalidad. Psiquiatría Biológica, 4, 181-186.
3. Connors, G. J., Maisto, S. A. y Donovan, D. M. (1996). Conceptualizations of relapse: a summary of psychological and psychobiological models. Addiction, 91, 5-14. doi: 10.1046/j.1360-0443.91.12s1.17.x
4. Fendrich, M., Johnson, T. P., Sudman, S., Wislar, J. S. y Spiehler, V. (1999). Validity of drug use reporting in a high-risk community sample: A comparison of cocaine and heroin survey reports with hair tests. American Journal of Epidemiology, 149, 955-962.
5. First, M. B., Gibbon, M., Spitzer, R. L., Williams, J. B. W. y Benjamin, L. S. (1999). The structured clinical interview for DSM-IV axis II disorder (SCID-II). New York: Biometrics Research Department, New York State Psychiatric Institute.
6. Fischer, B., Rehm, J., Kirst, M., Casas, M., Hall, W., Krausz, M.,...Van Ree J. M. (2002). Heroin-assisted treatment as a response to the public health problem of opiate dependence. European Journal of Public Health, 12, 228-234. doi:10.1093/eurpub/12.3.228
7. Goeb, J. L., Coste, J., Bigot, T. y Ferrand, I. (2000). [Prospective study of favorable factors in follow-up of drug addicted patients-a propos of 257 patients of the Cassini Center in Paris]. Encephale, 26, 11-20.
8. Gossop, M. (1978). Drug dependence: A study of the relationship between motivational, cognitive, social and historical factors, and treatment variables. Journal of Nervous and Mental Disease, 166, 44-50.
9. Gottheil, E., Thornton, C., Skoloda, T. y Alterman, A. (1982). Followup of abstinent and nonabstinent alcoholics. American Journal of Psychiatry, 139, 560-565.
10. Guirado, V., Freixa, M., Guardia, J., Salafranca, Ll. y Turbanny, J. (1994). Predicción del riesgo de recaída en tratamientos de drogodependientes. Adicciones, 6, 453-463.
11. Maddux, J. y Desmond, D. (1986). Relapse and recovery in substance abuse careers. NIDA Research Monograph, 72, 49-71.
12. Malow, R., West, J. y Williams, J. (1989). Personality disorders classifications and symptoms in cocaine and opioid addicts. Journal of Consulting and Clinical Psychology, 57, 765-767. doi:10.1037/0022-006X.57.6.765
13. Maremmani, A. G., Dell'Osso, L., Pacini, M., Popovic, D., Rovai, L., Torrens, M.,...Maremmani, I. (2011). Dual diagnosis and chronology of illness in treatment-seeking Italian patients dependent on heroin. Journal of Addictive Diseases, 30, 123-135. doi: 10.1080/10550887.2011.554779
14. McMahon, R. C. y Enders, C. (2009). Personality disorder factors predict recovery of employment functioning among treated cocaine abusers. The American Journal of Drug and Alcohol Abuse, 35, 138-144. doi: 10.1080/00952990902825397
15. Milkman, H., Weiner, S. E. y Sunderwirth, S. (1984). Addiction relapse. Advances in Alcohol and Substance Abuse, 3, 119-134.
16. Monrás, M., Lligoña, A., Freixa, N. y Gual, A. (2004). El último consumo de alcohol previo al ingreso de desintoxicación como predictor a largo plazo de la abstinencia. Adicciones, 16, 1-5.
17. Murphy, D. A., Hser, Y. I., Huang, D., Brecht, M. L. y Herbeck, D. M. (2010). Self-report of Longitudinal Substance Use: A Comparison of the UCLA Natural History Interview and the Addiction Severity Index. Journal Drug Issues, 40, 495-516.
18. O'Brien, C.P. y McLellan, A.T. (1996). Myths about the treatment of addiction. The Lancet, 347, 237-240. doi: 10.1016/S0140-6736(96)90409-2
19. Olmos-Espinosa, R., Madoz-Gúrpide, A. y Ochoa, E. (2001). [One year follow-up of opiate addicts in an outpatient programme after in-hospital detoxification] Adicciones, 13, 173-178.
20. Pérez de los Cobos, J., Trujols, J., Ribalta, E. y Casas, M. (1997). Cocaine use immediately prior to entry in an inpatient heroin detoxification unit as a predictor of discharges against medical advice. The American Journal of Drug and Alcohol Abuse, 23, 267-279. doi: 10.3109/00952999709040946
21. Pérez de los Cobos, J., Siñol, N., Trujols, J., Bañuls, E., Batlle, F. y Tejero, A. (2011). Drug-dependent inpatients reporting continuous absence of spontaneous drug craving for the main substance throughout detoxification treatment. Drug Alcohol Review, 30, 403-410. doi: 10.1111/j.1465-3362.2010.00241
22. Preston, K. L., Vahabzadeh, M., Schmittner, J., Lin, J. L., Gorelick, D. A. y Epstein, D. H. (2009). Cocaine craving and use during daily life. Psychopharmacology, 207, 291-301. doi: 10.1007/s00213-009-1655-8
23. Prochaska, J. O. y DiClemente, C. C. (1982). Transtheoretical therapy: Toward a more integrative model of change. Psychology and Psychotherapy: Theory, Research and Practice, 20, 161-173.
24. Roncero, C., Barral, C., Grau-López, L., Bachiller, D., Szerman, N., Casas, M. y Ruiz, P. (2011a). Protocols of dual diagnosis intervention in schizophrenia. Addictive Disorders and Their Treatment, 10, 131-154.
25. Roncero, C., Grau-López, L., Díaz-Morán, S., Miquel, L., Martínez-Luna, N. y Casas, M. (2011b). Evaluación de las alteraciones del sueño en pacientes drogodependientes. Medicina Clinica, 19. Medicina Clínica (Barcelona), 138, 332-335.
26. Rosenberg, H. (2009). Clinical and laboratory assessment of the subjective experience of drug craving. Clinical Psychology Review, 29, 519-534.
27. Rubio, G., León, G., Pascual, F. F. y Santo-Domingo, J. (1998). Clinical significance of Cloninger's classification in a sample of alcoholic Spanish men. Addiction, 93, 93-101. doi: 10.1046/j.1360-0443.1998.931939.x
28. Rubio, G., Jiménez, M., Rodríguez-Jiménez, R., Martínez, I., Iribarren, M. M., Jiménez-Arriero, M. A.,... Ávila, C. (2007). Varieties of impulsivity in males with alcohol dependence: the role of Cluster-B personality disorder. Alcoholism, Clinical and Experimental Research, 31, 1826-1832. doi: 10.1111/j.1530-0277.2007.00506.x
29. Rubio, G., Martínez-Gras, I. y Manzanares, J. (2009). Modulation of impulsivity by topiramate: implications for the treatment of alcohol dependence. Journal of Clinical Psychopharmacology, 29, 584-589. doi: 10.1097/JCP.0b013e3181bfdb79
30. Sánchez, L., Díaz-Morán, S., Grau-López, L., Moreno, A., Eiroa-Orosa, F. J., Roncero, C.,... Casas, M. (2011). Tratamiento ambulatorio grupal para dependientes de cocaína combinando terapia cognitiva conductual y entrevista motivacional. Psicothema, 23, 107-113.
31. Sánchez-Hervás, E., Secades-Villa, R., Santonja, F. J., Zacarés, F., García- Rodriguez, O., Martín, E.,...García Fernández, G. (2010). Abandono del tratamiento en adictos a la cocaína. Adicciones, 22, 59-64.
32. Santos, P., Palomares, J. V. y Pastor, M. A. (2000). Variables predictoras de evolución en una unidad de deshabituación residencial. Adicciones, 12, 487-491.
33. Secades, R. y Fernández, J. R. (2000). Cómo mejorar las tasas de retención en los tratamientos de drogodependencias. Adicciones, 12, 353-363.
34. Segal, D. L., Hersen, M. y Van Hasselt, V. B. (1994). Reliability of the Structured Clinical Interview for DSM-III-R: an evaluative review. Comprehensive Psychiatry, 35, 316-327.
35. Simpson, D.D. (1981). Treatment for drug abuse: follow-up outcomes and length of time spent in treatment. Archives of General Psychiatry, 38, 875-880.
36. Smith, B. P., Barry, J., Keenon, E. y Dukray, K. (2010). Lapse and relapse following inpatient treatment of opiate dependence. Irish Medical Journal, 103, 176-179.
37. Spitzer, R., Robert, L. y Gibbon, M. (1996). SCID-I, Versión clínica, entrevistaclínica estructurada para los trastornos del eje I del DSM. Masson: Barcelona.
38. Swett, C. y Noones, J. (1989). Factors associated with premature termination from outpatient treatment. Hospital and Community Psychiatry, 40, 947-951.
39. Torrens, M., Martin-Santos, R. y Samet, S. (2006). Importance of clinical diagnoses for comorbidity studies in substance use disorders. Neurotoxicity Research, 10, 253-261. doi: 10.1007/BF03033361
40. Tucker, J. A., Vuchinich, R. E. y Gladsjo, J. A. (1991). Environmental influences on relapse in substance use disorders. The International Journal of Addictions, 25, 1017-1050.
41. Volpicelli, J. R., Rhines, K. C., Rhines, J. S., Volpicelli, L. A., Alterman, A. I. y O'Brien, C.P. (1997). Naltrexone and alcohol dependence. Role of subject compliance. Archives of General Psychiatry, 54, 737-742.
42. Walton, M. A., Reischl, T. M. y Ramanthan, C. S. (1995). Social settings and addiction elapse. Journal of Substance Abuse, 7, 223-233. doi: 10.1016/0899-3289(95)90006-3
43. Wexler, H. K. y De Leon, G. (1977). The Therapeutic Community: Multivariate Prediction of Retention. The American Journal of Drug and Alcohol Abuse, 4, 145-151. doi: 10.3109/00952997709002756
44. Xie, H., McHugo, G. J., Fox, M. B. y Drake, R. E. (2005). Substance abuse relapse in a ten-year prospective follow-up of clients with mental and substance use disorders. Psychiatric Services, 56, 1282-1287. doi: 10.1176/appi.ps.56.10.1282